LOS ANGELES, Feb. 2, 2024 /PRNewswire/ -- Bruin Biometrics LLC announces repeated formal recognition of the role of sub-epidermal moisture (SEM) in the identification of the increased risk of pressure injuries and of the Provizio SEM Scanner in the detection, and guided treatment of SEM for the prevention of broken skin pressure injuries..

洛杉矶，2024年2月2日/PRNewswire/--Bruin Biometrics LLC宣布，反复正式承认表皮下水分（SEM）在识别压力性损伤风险增加中的作用，以及Provizio SEM扫描仪在检测中的作用，并指导SEM治疗以预防皮肤破裂压力性损伤。。

Martin Burns, CEO of Bruin Biometrics, brings good news: 'An increasing number of national and expert guidelines now recognize SEM assessment for pressure injury prevention due to the latest data on the ongoing challenges of pressure injuries and the importance of their prevention.

Bruin Biometrics首席执行官马丁·伯恩斯（MartinBurns）带来了好消息：“越来越多的国家和专家指南现在认可SEM评估预防压力伤害，因为最新数据表明压力伤害的持续挑战及其预防的重要性。

FDA, CMS, and device users now acknowledge the importance of that clinical foresight, which is acutely true for dark-skin-toned patients. Health economic modelling underscores its cost-effectiveness whilst freeing up healthcare practitioner time.

FDA、CMS和设备用户现在认识到这种临床预见的重要性，这对于皮肤黝黑的患者来说是非常正确的。健康经济模型强调了其成本效益，同时节省了医疗保健从业者的时间。

2023 was a year of groundbreaking clinical and health economic advancements with the Provizio SEM Scanner, the name of which was selected to suggest and highlight the 'foresight' this technology provides. The company and its collaborating practitioners and exclusive global distributor, Arjo, continue to modernise the landscape of pressure injury prevention in the US, with far-reaching positive effects for patients, globally..

2023年是Provizio SEM扫描仪在临床和健康经济方面取得突破性进展的一年，该扫描仪的名称被选为建议和突出该技术提供的“远见”。该公司及其合作从业者和全球独家经销商Arjo继续在美国实现压力伤害预防的现代化，对全球患者产生深远的积极影响。。

In the United States:

在美国：

The FDA has acknowledged that sub-epidermal moisture is the equivalent of persistent focal edema and localized edema: additionally, that sub-epidermal moisture is measured and monitored by the Provizio SEM Scanner, accepting an expanded labelling (K231830, September 2023).

FDA已经承认，表皮下水分相当于持续性局灶性水肿和局部水肿：此外，表皮下水分由Provizio SEM扫描仪测量和监测，并接受扩大标记（K2318302023年9月）。

The US Centers for Medicare and Medicaid (CMS) has approved the ICD-10 PCS procedure code, XX2KXP9, for the SEM scanning procedure, effective April 1, 2024, It recognizes the utility of the technology in measuring and monitoring SEM which, when treated, significantly aids in preventing pressure injuries and deep tissue injuries.

美国医疗保险和医疗补助中心（CMS）已批准ICD-10 PCS程序代码XX2KXP9用于SEM扫描程序，自2024年4月1日起生效，它认识到该技术在测量和监测SEM方面的实用性，该技术在治疗后可显着帮助预防压力伤和深部组织损伤。

This new code will play a significant role in promoting standardization of the procedure, especially for present on admission testing which is a major quality risk area for providers with consequential Medicare penalties for missed diagnoses..

这项新法规将在促进程序标准化方面发挥重要作用，特别是对于目前的入院检测，这是医疗保险对漏诊进行相应处罚的提供者的主要质量风险领域。。

These developments have broad implications for clinical practice. In the US, the 1% Medicare penalty for hospital-acquired pressure injuries again applies to clinical practice for the fiscal year from October 1, 2023, to September 30, 2024. Because of these Provizio SEM Scanner related milestones, healthcare providers and practitioners have coded procedures and a powerful tool for identifying and documenting pressure damage on admission, and Deep Tissue Injuries; and in particular for dark-skin toned patients..

这些发展对临床实践具有广泛的意义。在美国，2023年10月1日至2024年9月30日的财政年度，医院获得性压力性损伤的1%医疗保险罚款再次适用于临床实践。由于这些Provizio SEM扫描仪相关的里程碑，医疗保健提供者和从业者已经编码了程序和强大的工具，用于识别和记录入院时的压力损伤和深部组织损伤；尤其是皮肤黝黑的患者。。

For years, healthcare practitioners and policymakers have been frustrated from increased pressure injury incidence and associated resource burdens and treatment costs. From Bruin Biometrics' point of the view the current status quo around pressure injuries is simply inadequate resulting in too much avoidable patient suffering..

多年来，医疗保健从业者和政策制定者一直因压力伤害发病率增加以及相关的资源负担和治疗费用而感到沮丧。从布鲁因生物特征学的角度来看，目前压力伤害的现状根本不足以导致太多可避免的患者痛苦。。

Burns concluded, 'These approvals and authorizations are proverbial breaths of fresh air in a clinical area frustrated by detection, treatment and prevention methods not grounded in the contemporary etiology and pathophysiology. We have moved beyond the era of pressure injury risk-tools and visual and tactile skin assessments alone, and into an era where objective, microscopic measures guide practitioners' understanding of their patients' skin and tissue status.'.

伯恩斯总结道，“这些批准和授权是众所周知的呼吸新鲜空气的临床领域，由于检测，治疗和预防方法不符合当代病因学和病理生理学，因此受到挫折。我们已经超越了压力伤害风险工具和视觉和触觉皮肤评估的时代，进入了一个客观的微观测量指导从业者了解患者皮肤和组织状态的时代。

* A pressure injury can also be known as a pressure ulcer, pressure sore, decubitus ulcer and bed sore.

*压疮也称为压疮、压疮、褥疮和褥疮。

For more information, please visit www.sem-scanner.com or contact Kate Hancock, EVP External Communications, at +447827315347 or [email protected].

有关更多信息，请访问www.sem-scanner.com或联系外部通信执行副总裁Kate Hancock，电话：+447827315347或[受电子邮件保护]。

Media contact details:

媒体联系方式：

Joanna Dodd, Alicia Barkle Rochester PR Group : [email protected] / [email protected]

Joanna Dodd，Alicia Barkle Rochester公共关系集团 : [受电子邮件保护]/[受电子邮件保护]

1 K231830, September 2023: 'The Provizio SEM Scanner S measures the electrical capacitance of tissue ('Biocapacitance'), below the electrode when placed on the patient's skin. Biocapacitance is a biophysical measure of changes in sub-epidermal moisture ('SEM') a physiological process associated with pressure-induced tissue damage, The Provizio SEM Scanner is designed to measure changes in SEM which is equally known in literature as persistent focal edema, or localized edema..

1 K2318302023年9月：“Provizio SEM扫描仪S测量放置在患者皮肤上时电极下方组织的电容（“生物电容”）。生物电容是表皮下水分变化的生物物理测量（“SEM”）是一种与压力引起的组织损伤相关的生理过程，Provizio SEM扫描仪旨在测量SEM的变化，SEM在文献中被称为持续性局灶性水肿或局部水肿。。

About Bruin Biometrics

关于布鲁因生物特征

Bruin Biometrics, LLC, is a pioneer in modernizing health care with biometric sensor technology for early detection and monitoring of chronic, preventable conditions in collaboration with clinicians.

Bruin Biometrics，LLC是通过生物传感器技术实现医疗保健现代化的先驱，可与临床医生合作，早期发现和监测慢性可预防疾病。

Bruin Biometrics work on SEM Assessment Technology has been recognized with multiple global healthcare innovation awards and is implemented in healthcare facilities across a variety of care settings. Bruin Biometrics HQ is based in Los Angeles.

布鲁因生物特征学在SEM评估技术方面的工作已获得多项全球医疗创新奖的认可，并在各种医疗机构的医疗机构中实施。布鲁因生物识别总部位于洛杉矶。

SOURCE Bruin Biometrics, LLC

来源Bruin Biometrics，LLC